These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38552427)

  • 21. A transdermal drug delivery system based on dissolving microneedles for boron neutron capture therapy of melanoma.
    Li J; Wang X; Wang Z; Zhao Y; Zhang Z; Li L; Ding D; Guo J; Zhang J; Liu H; Li Z
    Biomater Sci; 2023 Nov; 11(23):7568-7578. PubMed ID: 37861462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of boron neutron capture therapy for melanotic and amelanotic melanoma transplanted into mouse brain.
    Iwakura M; Kondoh H; Hiratsuka J; Ehara K; Tamaki N; Mishima Y
    Pigment Cell Res; 2002 Feb; 15(1):67-75. PubMed ID: 11837459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From Nuclear Reactor-Based to Proton Accelerator-Based Therapy: The Finnish Boron Neutron Capture Therapy Experience.
    Porra L; Wendland L; Seppälä T; Koivunoro H; Revitzer H; Tervonen J; Kankaanranta L; Anttonen A; Tenhunen M; Joensuu H
    Cancer Biother Radiopharm; 2023 Apr; 38(3):184-191. PubMed ID: 36269660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-Aminolevulinic acid increases boronophenylalanine uptake into glioma stem cells and may sensitize malignant glioma to boron neutron capture therapy.
    Fukumura M; Nonoguchi N; Kawabata S; Hiramatsu R; Futamura G; Takeuchi K; Kanemitsu T; Takata T; Tanaka H; Suzuki M; Sampetrean O; Ikeda N; Kuroiwa T; Saya H; Nakano I; Wanibuchi M
    Sci Rep; 2023 Jun; 13(1):10173. PubMed ID: 37349515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax.
    Wang P; Zhen H; Jiang X; Zhang W; Cheng X; Guo G; Mao X; Zhang X
    BMC Cancer; 2010 Dec; 10():661. PubMed ID: 21122152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early effect of boron neutron capture therapy mediated by boronophenylalanine (BPA-BNCT) on mast cells in premalignant tissue and tumors of the hamster cheek pouch.
    Aromando RF; Trivillin VA; Heber EM; Pozzi E; Schwint AE; Itoiz ME
    Oral Oncol; 2010 May; 46(5):355-9. PubMed ID: 20308008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
    Chandra S; Ahmad T; Barth RF; Kabalka GW
    J Microsc; 2014 Jun; 254(3):146-56. PubMed ID: 24684609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Boronated compounds for imaging guided BNCT applications.
    Geninatti-Crich S; Deagostino A; Toppino A; Alberti D; Venturello P; Aime S
    Anticancer Agents Med Chem; 2012 Jun; 12(5):543-53. PubMed ID: 22263798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitors of CA IX Enzyme Based on Polyhedral Boron Compounds.
    Kugler M; Nekvinda J; Holub J; El Anwar S; Das V; Šícha V; Pospíšilová K; Fábry M; Král V; Brynda J; Kašička V; Hajdúch M; Řezáčová P; Grüner B
    Chembiochem; 2021 Sep; 22(18):2741-2761. PubMed ID: 33939874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Boron neutron capture therapy (BNCT) for the treatment of liver metastases: biodistribution studies of boron compounds in an experimental model.
    Garabalino MA; Monti Hughes A; Molinari AJ; Heber EM; Pozzi EC; Cardoso JE; Colombo LL; Nievas S; Nigg DW; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
    Radiat Environ Biophys; 2011 Mar; 50(1):199-207. PubMed ID: 21132507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility study on the utilization of boron neutron capture therapy (BNCT) in a rat model of diffuse lung metastases.
    Bakeine GJ; Di Salvo M; Bortolussi S; Stella S; Bruschi P; Bertolotti A; Nano R; Clerici A; Ferrari C; Zonta C; Marchetti A; Altieri S
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S332-5. PubMed ID: 19394841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding the potentiality of accelerator based-boron neutron capture therapy for osteosarcoma: dosimetry assessment based on the reported clinical experience.
    Bortolussi S; Postuma I; Protti N; Provenzano L; Ferrari C; Cansolino L; Dionigi P; Galasso O; Gasparini G; Altieri S; Miyatake SI; González SJ
    Radiat Oncol; 2017 Aug; 12(1):130. PubMed ID: 28806981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel boronated-porphyrin as a radio-sensitizing agent for boron neutron capture therapy of tumours: in vitro and in vivo studies.
    Jori G; Soncin M; Friso E; Vicente MG; Hao E; Miotto G; Colautti P; Moro D; Esposito J; Rosi G; Nava E; Sotti G; Fabris C
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S321-4. PubMed ID: 19376726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards carborane-functionalised structures for the treatment of brain cancer.
    Calabrese G; Daou A; Barbu E; Tsibouklis J
    Drug Discov Today; 2018 Jan; 23(1):63-75. PubMed ID: 28886331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Model for Estimating Dose-Rate Effects on Cell-Killing of Human Melanoma after Boron Neutron Capture Therapy.
    Matsuya Y; Fukunaga H; Omura M; Date H
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
    Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH
    Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of boron neutron capture therapy (BNCT) for malignant pleural mesothelioma from a viewpoint of dose distribution analysis.
    Suzuki M; Sakurai Y; Masunaga S; Kinashi Y; Nagata K; Maruhashi A; Ono K
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1584-9. PubMed ID: 17056195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
    Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine.
    Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH
    J Neurooncol; 1997 May; 33(1-2):59-70. PubMed ID: 9151224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Boron neutron capture therapy for murine malignant gliomas.
    Saris SC; Solares GR; Wazer DE; Cano G; Kerley SE; Joyce MA; Adelman LS; Harling OK; Madoc-Jones H; Zamenhof RG
    Cancer Res; 1992 Sep; 52(17):4672-7. PubMed ID: 1511433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.